Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $59.1100 (-11.47%) ($58.9300 - $59.1100) on Wed. Feb. 10, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.91% (three month average) | RSI | 45 | Latest Price | $59.1100(-11.47%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.9% a day on average for past five trading days. | Weekly Trend | EDIT advances 1.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(66%) IWO(62%) IWC(59%) IBUY(58%) IWM(57%) | Factors Impacting EDIT price | EDIT will decline at least -3.955% in a week (0% probabilities). VIXM(-32%) UUP(-16%) VXX(-13%) TBT(-7%) UNG(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.955% (StdDev 7.91%) | Hourly BBV | -1.9 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $65.83 | 5 Day Moving Average | $64.58(-8.47%) | 10 Day Moving Average | $63.66(-7.15%) | 20 Day Moving Average | $65.83(-10.21%) | To recent high | -35% | To recent low | 113.2% | Market Cap | $3.671b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |